Aurora Therapeutics
1 known investors
Aurora develops a platform for personalized gene editing to treat rare genetic diseases at scale. The company targets patients with rare disease variants by systematizing and scaling gene editing treatments to address genetic mutations that lack existing therapeutic options.
BiotechDeep TechMedical Devices
Investors · 1
In the news
- Aurora Therapeutics Raises $16.0M Seed | SignalBasetrysignalbase.com · 2026
- Aurora Therapeutics launches to develop CRISPR therapies for rare diseasescen.acs.org · 2026
- Key scientist from Baby KJ team launches startup to scale personalized CRISPR medicinesstatnews.com · 2026
- Gene editing pioneers launch first startup focused on custom CRISPR therapiesendpoints.news · 2026
- Baby KJ scientist launches personalized CRISPR therapy startupfiercebiotech.com · 2026
- CRISPR’s First One-Patient Success Is Becoming a Company: Aurora Launches With $16M to Scale Bespoke Gene Editingbiopharmatrend.com · 2026